Skip to main content
SpringerLink
Log in

Value of neutrophil lymphocyte ratio in patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib

  • Letter to the Editor
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wei K, Wang M, Zhang W, et al. Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib. Med Oncol. 2014;31:969.

    Article  PubMed  Google Scholar 

  2. Tanoglu A, Karagoz E, Yiyit N, et al. Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? Onco Targets Ther. 2014;7:433–4.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Erturk M, Cakmak HA, Surgit O, et al. The predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol. 2014. doi:10.1016/j.jjcc.2014.02.019.

  4. Alkhouri N, Morris-Stiff G, Campbell C, et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32:297–302.

    Article  CAS  PubMed  Google Scholar 

  5. Imeri F, Herklotz R, Risch L, et al. Stability of hematological analytes depends on the hematology analyser used: a stability study with Bayer Advia 120, Beckman Coulter LH 750 and Sysmex XE 2100. Clin Chim Acta. 2008;397:68–71.

    Article  CAS  PubMed  Google Scholar 

  6. Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002;26:659–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Agri Military Hospital, Agri, Turkey

    Mehmet Agilli

  2. Department of Biochemistry, Sirnak Military Hospital, Sirnak, Turkey

    Fevzi Nuri Aydin

  3. Department of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey

    Yasemin Gulcan Kurt

Authors
  1. Mehmet Agilli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fevzi Nuri Aydin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasemin Gulcan Kurt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehmet Agilli.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agilli, M., Aydin, F.N. & Kurt, Y.G. Value of neutrophil lymphocyte ratio in patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib. Med Oncol 31, 68 (2014). https://doi.org/10.1007/s12032-014-0068-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0068-7

Keywords

Search

Navigation